Eton Pharmaceuticals, Inc. — Director's Dealing 2021

Jun 21, 2021

SEC Form 4/A — Form 4/A

Issuer: Eton Pharmaceuticals, Inc. (ETON)
CIK: 0001710340
Period of Report: 2021-06-15

Reporting Person: Opaleye Management Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-15	Common Stock, par value $0.001 per share	S	101000	$8.07	Disposed	3551100	Indirect
2021-06-15	Common Stock, par value $0.001 per share	S	4000	$8.07	Disposed	141600	Indirect

Footnotes

F1: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

F2: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Managed Account.